How These Founders Built Billion-Dollar Industry Disruptors Despite Investor Skepticism

NK MEDIA
4 followers
2 Video Views·Sep 14, 2026
Kate Ryder, Founder & CEO of Maven Clinic and Caryn Seidman Becker, Chairman & CEO of CLEAR, sat down with Maggie McGrath to reflect on early struggles and share how they turned investor skepticism into massive healthcare and security empires.
AI Generated·May contain errors
Video Summary
AI GeneratedTwo female founders of Maven and Clear discuss their journeys in building billion-dollar companies by addressing systemic gaps in women's healthcare and identity security. They emphasize resilience in the face of skepticism, the importance of strategic advocacy, and the integration of AI to scale their impact and improve user experiences.
These are two women who had a vision well over a decade ago,
and those visions are both worth more than a billion dollars.
Kate's company is valued at 1.7.
Karen, I pulled Clear Secure stock before market open.
So before market open, it was 5.8 billion dollars.
Yes, you can clap for that.
And there's also some synergy between the two.
I know Kate is a proud Clear member,
and there are some other synergies
that I don't know if I'm allowed to say publicly, but.
You can, we're proud Raven customers.
There you go.
So you're all.
A new customer.
New customer.
So we're so thrilled.
But I want to ask, because I started with the vision
happening more than a decade ago, I added the valuations.
Do you want to take this moment
to say I told you so to anyone?
No, there's no premature victories in this industry.
I think it's, I think, yeah, it's great to be here,
and we're only 5% of the way into our roadmap.
So we still have a long way to go.
Still day one, but there was one guy
who shall go nameless at a VC that shall go nameless
that said, you know, what makes you think
you could be CEO of this company?
And he was quite dismissive.
So we are still on day one and have a ways to go,
but I carried his picture around for a long time
on my phone as a motivator.
You turn your negative into a positive,
I have a lot of gratitude for him.
Scott.
I start.
On a more serious note, you both did identify
market opportunities that other investors, founders,
the market in general had overlooked.
As you think back to the light bulb moment
for your companies, what did each of you see
that you think the market was missing?
I'll start with you.
Sure, well, so I started Maven 11 years ago.
I was in London.
I didn't have kids yet.
I now have three kids, but it was right
when my friends were starting to have kids.
And so the stories around postpartum depression
or IVF that was really hard to afford
were coming fast and furious.
And what was really interesting is it wasn't just Americans
in my text messages with my friends at home.
It was literally a global thing.
There is not a single health system in the entire world
that is like amazingly and uniquely serves women's needs,
at least during this time.
And I think now as women's health has evolved
over the last 10 years and menopause
is a huge conversation now, that too is just like
a massive gap, not just in the US, but globally.
And so I started, of course, with the patient.
I think that when you're a founder
and you're building, we may sell both benefits
and now we have a consumer health product,
but we've always built our product as a consumer product.
And so I feel like our unique advantage
and mine as a founder is like,
I just really know the consumer
because I've lived all of the different journeys,
whether it's miscarriage or pregnancy or IVF.
I'm now in perimenopause, I'm in my 40s.
And so there was clearly such a unique opportunity there.
There was a lot of need, but I was also,
I was a journalist before starting Maven with The Economist.
And so I also approached it as a story to report out
because healthcare is an industry
with a lot of different stakeholders.
There's the buyer, there's the employer,
there's the health plan, there's the provider,
not just the patient.
And so, and when you report out the story,
you really not only see that the patient
is massively underserved,
but you start to see massive economic
and commercial opportunity
because women are 80% of the healthcare industry
when it comes to making decisions,
which means they control the spend
in a $5 trillion industry.
It means that in this on-ramp to healthcare,
which is oftentimes starting a family,
she is so underserved.
And so there's an opportunity to create amazing products.
And then as you kind of go through
all of the different parts of a woman's life,
you can just really reimagine what a more accessible
and inclusive care model would look like.
And you can actually do that virtually.
Like there's a lot that needs to happen in person,
but there's a lot you can do around access and virtual care.
And so anyway, so that was where things were.
Very naive founder, I've not worked in healthcare before.
But that's kind of how you have to start.
I mean, I was hungry and really excited to make impact.
And I still actually feel that energy,
healthcare is changing so much right now.
I still feel the energy 12 years in.
I think sometimes it's better to not know what you don't know
because then there's nothing to be afraid of.
Karen, you bought Clear out of bankruptcy
for $6 million in 2010.
A lot of people know it for airport security.
It's become so much more,
which you said was in one of the initial slide decks.
So can you take us back to 2010?
What was that vision?
What is on that slide deck?
Yeah, so 16 years ago, page one of our slide deck said,
today it's a travel-centric company,
tomorrow it's the de facto secure identity platform.
We didn't say healthcare, but quickly thought about it.
And the reason why was a few things.
As we come upon the 25th anniversary tomorrow of 9-11,
9-11 changed me at the time
of both what could happen in our country,
the need for greater safety and security,
and what our moral obligation as citizens was
to be a part of that change.
It was also when I started Clear,
I had three children, little ones,
and you live in life as a working mom
on a very thin thread,
and I wanted a frictionless experience,
and I was paranoid about terrorism and security,
and Clear really was the convergence
of making experiences safer and easier
physically and digitally.
This concept of you are always you,
I challenge everyone here, look at your bags,
they're so big, there's the stuff at the bottom
that you're trying to pull out
when getting through airport security,
building access, getting into the pediatrician's office,
refilling out the clipboard with all of the information
when you go to a different doctor.
And to me, it was all crazy.
That's not frictionless, it's not efficient,
it's not secure, it's not a great customer experience,
it's not a great provider experience.
And I also saw a lot of structural similarities
between an airport, think about it,
you go in, you're a number, nobody's there to help you,
it's all confusing, each one is new and different,
except for your home airport, and a hospital.
It's like the world of the unknown,
and they still are using CD-ROMs and faxes,
getting into an office building,
they give you a sticker with a QR code,
you go through the thing.
You're just saying you are you,
and my view was enroll once, use everywhere,
make experiences safer and easier,
physically and digitally,
and today what we really talk about
is from homeland security to cyber security,
never has it been more important,
and that Clear could be also the partner
to secure data, to secure privacy,
to do it in an opt-in way,
and so that's what we've been at for 16 years,
and we're closing in on 50 million members on the platform,
and who doesn't wanna get,
if you trusted your partner,
and for us we wanna be the trusted,
secure identity company,
if you trusted your partner,
who wouldn't wanna use their face
to get through life in a more frictionless and secure way?
To say nothing of all the passwords
that I have written down on pen and paper,
and it's getting worse,
and then you get the push notification on your phone,
and you're like, my phone's in the other room,
and then the thing expires,
that is not how we should go through life,
and then you look at all the hackings,
and the breaches,
like this is such a moment,
identity matters,
and so 16 years later,
we're still, we're early days,
and we're at it,
and ignorance is absolutely bliss,
if you knew how hard this was,
and how many haters there were,
I don't know that you'd jump in with two feet,
but it is so awesome when you're like,
this is right,
and we're just on the side of right.
I know you both say you're still early days,
but there's a lot of progress
both of your companies have made,
but for folks in the room
who might be starting their own thing,
I know there were certain parts of your early stories
that were challenging.
Kate, you've talked about
how when you were raising your Series A,
it was probably one of the most
financially precarious times for the company.
Can you talk about what gave you the conviction
to steer through that moment?
Yes, well, there's now a little bit more
female representation in venture capital,
but when we were raising the Series A,
there was literally zero.
There was, you know,
I think it was for every 10 meetings I would have,
maybe, you know,
they would bring the female associate in,
so I would see a few women through the journey.
But it was, this was 2016,
and, you know, when you walk,
when I would walk into a room,
I've just described the massive economic opportunity
when you uniquely serve women
with a better care model in healthcare.
It's, you know, one, it is,
like, when you put the numbers on a page
and then you put it next to, like,
even a, you know, a SaaS company
doing some, you know, DocuSign type thing,
like, the numbers are much bigger,
and yet the investors were so much more interested
in that self-driving car company or the SaaS company.
They just weren't interested.
And that is kind of one of the problems
and why you need diversity in venture capital is,
you know, if you're an investor
and you're only making two to three investments a year,
like, it makes sense.
Like, I would invest in things that I'm interested in
if you saw, you know,
20, 30 good potential business ideas
and good potential businesses.
Because Series A, you're still very early,
so you're selling the vision
as much as you are your early metrics.
And so I think it was, like, 40 or 50 rejections.
And some of them, like, we would get really, really close
and there would be some dad who, like, really got it
and, you know, had seen his wife go through,
you know, a massive, like, postpartum experience.
And then he would bring me to the partnership
and I would walk into the room and I'd be like,
ugh, one woman here, no women here.
And so I think it was just truly,
it was seeing the impact we were already having
with our patients on the platform,
seeing that the providers,
providers in women's health are incredible
because they are on the front lines
of a massively underserved group of women and patients.
And so just kind of, like,
when you look at your own product
and you just, you see the impact,
it really drove me.
And so there's this one funny story where I actually,
I, in the early days, we had no marketing money.
And so we were hustling around New York City.
Like, I was personally in, like, Washington Square Park
being like, try this new product, try this new product.
And you know, this was 2016, 2015.
Like, people didn't really understand telomeres
and yet COVID hadn't hit.
And so there was this one girl that had just started at NYU.
And so she tried,
she didn't want to go to Planned Parenthood
to get her birth control.
So she got her birth control through Maven.
And she texted me and it was, like,
right after maybe, like, the 39th rejection.
And she texted me that night,
because then I was like, oh my God, you're 18 in the city.
Like, here's my number, call me if you need anything.
And so then, so she texted me and she goes,
this was incredible.
I'm going to be talking, this is my new OB.
I also, like, gave this to all the girls on my floor
in her dorm.
And that, like, things like that just really, really,
you know, keep you going during the really tough times.
Karen, I know there are a few moments
we could point to COVID being a tough moment
for the travel industry.
Also, when you bought the company out of bankruptcy,
I've heard you say you got home.
It's like, what did we just do?
I know the 2022 to 24 regulatory environment.
It's like every other year.
Every other year.
So I feel like you could pick your struggle,
but the same question is,
for those who are building their own project,
company, initiative,
how did you get through any one of those difficult times?
So a few things.
One, you need one person to believe in you.
So for you, it was the 18-year-old girl for us.
First airport, the Orlando airport.
And when you get somebody who will give you a chance,
and everyone says, why did you start in Orlando?
I said, because they wanted us.
And because it was the land of Disney and Universal.
So they cared about hospitality,
customer experience, and security,
because it was the highest percentage
of first-time travelers coming through the Orlando airport.
Little-known cocktail party conversation.
So you need one.
For healthcare, quite frankly,
it was Dignity Health in 2019,
who said, we want to use it for check-in.
Then that went away because of COVID,
and we needed somebody to believe in our health paths.
And that was probably LabCorp.
And then after that, it was Wellstar,
and Dr. Hank Capps, who said, we believe in you,
and we want innovation, and we want check-in,
and we want to kill the clipboard,
which we came up with before the Trump administration,
but I love that they're saying it so they can have it.
But this whole concept of,
why are you trying to fill in all this
self-attested and important information?
And so you need one, and you needed Chris Klomp,
to say, we want to, and Dr. Oz,
to say, we want to fight fraud in Medicare.
And so identity is foundational to that.
So we're going to partner with the private sector.
And so it is, you need one person,
and when you do right by them, they will tell other people.
And I think that in a world of AI and all this,
which I'm obsessed with and love,
it is still the human factor to share my story,
to know that it's heart, mind, and hustle,
to know that we are partners, who when you say jump,
not only do we say how high we've already jumped,
to know that you can depend on us,
to know that you can trust us,
to know that we will innovate for you.
Like the power of partnership
and having one person believe in you is still what's viral.
Yeah, I mean, when you're trying to disrupt an industry
like Clear or Maven, I mean, it was, you know,
it gives me energy, but then our biggest commercial customer,
it was one man inside of Bank of America in 2017,
who was like, well, you will be our benefit.
We're going to take a chance on you.
It was, you know, one woman inside of United in 2020,
right when COVID hit,
and we were just building our health plan partnership.
And she worked in product there,
and she was like, we need this, we need to innovate.
But, you know, because the big institutions,
they aren't like that.
You need to find these trusted people.
So if you are those trusted people,
hold the hand of an innovator,
because truly it makes such a huge impact
as I look at these kind of crucible moments
through our last decade.
I actually host a video series for Forbes
called The One Who Changed Everything,
because I believe so fervently in the idea
that all it takes is one person to change the course
of a company or a career. One, you know, one.
But let's fast forward to today,
because both of you have had some really exciting
new developments for your businesses this year
or within the last six to 18 months.
So Karen, we've talked about Clear was airport security,
and then you came to the Forbes Healthcare Summit
a few years ago.
And at that time, the healthcare expansion
was more of a dream than a reality.
Today it's a reality,
but you were also telling me
about the CrowdStrike partnership.
Can you talk about why that's so important
for your business today?
Because it's from homeland security to cybersecurity, right?
When we said we wanted to be
the trusted secure identity company 16 years ago,
we certainly weren't thinking about agentic identity
and the fact that a workforce,
that workforces are being infiltrated by North Koreans,
right, who are then exfiltrating data.
You are seeing breaches today on a daily basis
in call centers and account recovery and password reset.
CrowdStrike is the leader in cybersecurity.
And so being an identity partner to their Falcone platform,
having identity at the front end of that cyber
to secure endpoints is so massively important.
And when you put these things together,
whether it be DocuSign or Okta,
who we are also partners with,
and put secure identity at the front end of that,
now you have true security.
And in the world of workforce,
whether it be at T-Mobile,
who's been very public about our partnership,
or at a hospital,
where there are also significant challenges,
you need security,
you need to know who the foundational person is
because when you have agents,
you go from one employee to 100 or 1,000 employees.
And so agentic identity in the workforce
means you need to know
that you are you at the foundational level,
who those agents are connected to,
and what they should have access to.
My agents should have access
to something different than somebody else's agents
that maybe they shouldn't have access to the HR files
or the board presentation.
And then if somebody leaves, who are their agents?
Who do you assign them to?
It's really complicated.
So our partnership with CrowdStrike is really powerful
as we continue to move forward in cybersecurity.
Kate, as far as Maven goes,
we've talked about how digital health
can be a way to plug some of the gaps in care.
There are so many maternal healthcare deserts,
as I'm sure this audience knows well,
but you have a new consumer offering this year.
So are you moving towards plugging all gaps in healthcare?
Yeah, it's so exciting
because it's actually where we started in 2015
when we launched.
We launched in consumer
and telemedicine was still too new.
The industry wasn't quite there yet.
And so we've grown over the last 10 years
where we work with 2,500 companies today
and we cover their employee benefits.
So we cover their IVF or the IVF benefit
or the health plan in fertility
and then we cover maternity and pediatrics and menopause.
And employers want that because A, it helps them reduce,
it drives better clinical impacts
in fertility and maternity
and then it brings access to their parents
and women who are kind of going through that stage of life.
There's so much more
beyond those kind of core reproductive areas.
And so over the last few years,
what's been really amazing
and what I think COVID kind of unleashed
and now kind of AI is unleashing yet again
is consumer health innovation
and there's an explosion in the ability
to bring data into our product
in ways that we've never been able to have data
to better personalize journeys
so that whether that's diagnostic data or EMR data
to use AI to kind of really be more proactive
and how we're nudging our patients
in terms of what they want
and even kind of understanding
what their health backgrounds are.
GLP-1s have come onto the market.
70% of GLP-1 users are women.
A lot of people don't know this
because particularly in perimenopause and menopause
when your metabolic rate resets,
there's a lot of women using GLP-1s
to kind of help them through that stage of life
is kind of one of the foundational things
that they're taking to help them
with longevity and aging
and so it's really exciting.
Testosterone usage in women,
there's all of these things now
that employers aren't gonna necessarily cover
because they shouldn't, by the way.
Employers can't cover everything,
particularly given, Karen and I are talking backstage
around the insane healthcare inflation
that is happening across all of our clients right now
where your healthcare costs are going up
10 to 20% every single year
and so there has to be a consumer market
to kind of allow consumers to have more choice
and more autonomy and more of a voice in healthcare
because that's been lacking particularly for women
but then also it's amazing to be able
to just lean into some of the new drugs
and the new technologies
to just, again, continue to reimagine a better experience.
And what we were talking about
was then the need for interoperability
and that's something that we're focused on.
So like partnering with Google,
if the data's in Fitbit,
it should end up in your health record with your doctors
and so identity is that interoperable layer,
bringing data interoperability
as you go to genetic testing, as you go to wearables,
it all needs to flow together.
If your Oura ring isn't talking to your doctor,
how helpful is that to know
that you might have a cardiac issue because of something
or what your sleep is telling you
and so putting this data together
and identity securing it is so important and powerful
to have better patient outcomes.
And it would save time too.
I don't know how many people have had the experience,
they get 11 minutes with their doctor
or maybe their doctor has gone concierge
and now that's a separate conversation, right?
But if it saves time, then that's important too.
But we are down to the last minute
and because you both said
that you are still in early days of your companies
in spite of them both being more than a decade old,
I'd love to end with something forward looking.
What can we expect from Maven and Clear in the coming year?
Kate, I'll start with you.
Sure, I think just bringing it all together
in a single front door where you can come to Maven
and get access to whatever you need.
Some of it's covered by your employer,
some of it's covered by your health plan,
some of it's paying out of pocket
but we have the right providers
and the right data and intelligence
to help you get what you need
based on your own unique history.
In travel, you can expect a seamless home to gate experience
with our app, with our concierges,
our ambassadors can now help you and your family through
who doesn't want an extra set of hands.
And then our eGates everywhere
and then we've launched coffee in LaGuardia and at Newark
because I personally want my coffee waiting for me
and not having to wait in line.
That is live in there.
I'm building a company for what I want.
And then on the clear, it's awesome.
And then on the clear one side,
certainly helping the government
and a big GovTech push to help fight fraud
and that's in healthcare, that's for veterans,
that's in IRS and social security
and all of those things to really help fight fraud
and to drive massive interoperability in healthcare
for better patient outcomes.
And with that, we are out of time.
Kate and Karen, thank you so much for your insights.
Always a pleasure.
